Power Solutions (PSIX) insider plans sale of 26,005 NASDAQ shares

Rhea-AI Filing Summary

Power Solutions International (PSIX) reported a Form 144 notice for a proposed sale of 26,005 shares of common stock through Wells Fargo Advisors on NASDAQ, with an aggregate market value of $2,492,600. The filing lists 23,029,846 shares outstanding, so the proposed sale represents approximately 0.113% of outstanding shares.

The filing details the acquisition history for the shares to be sold, showing compensatory grants and stock appreciation right exercises dated between 2016 and 2024 (individual lots of 786; 1,167; 6,209; 1,167; 3,780; 5,725; 6,505; and 8,520). The form states there were no securities sold by the filer in the past three months and includes the signer’s representation that they do not possess undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale notice; size is immaterial relative to float, so limited direct market impact.

The Form 144 shows a proposed sale of 26,005 shares valued at $2,492,600 executed through a broker on NASDAQ. Relative to 23,029,846 shares outstanding, this is about 0.11%, which is immaterial to overall capitalization. The acquisition history indicates the shares were largely received via compensatory grants and SAR exercises from 2016 to 2024, consistent with executive equity compensation monetization. No sales in the prior three months are reported, reducing immediate pattern concerns. Overall, this appears to be a routine, compliance-driven disclosure rather than a signal of material corporate change.

Corporate Governance Expert

TL;DR: Filing documents compliant disposal of equity from past compensation and SAR exercises; governance disclosure appears standard.

The schedule of acquisitions lists multiple compensatory grants and later SAR exercises, demonstrating traceable provenance of the shares being offered. The use of a broker and the Form 144 notice align with Rule 144 requirements for public sale by an affiliate. The filer’s representation that no material non-public information exists is standard language on this form. No unusual concentrations or rapid divestitures are apparent from the disclosed lot dates and sizes.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Wells Fargo Advisors P.O. Box 66535 St. Louis MO 63166	26005	2492600	23029846	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	06/17/2016	Compensatory Grant from Issuer	Issuer			786	06/17/2016	Compensatory Grant from Issuer
Common Stock	06/17/2017	Compensatory Grant from Issuer	Issuer			1167	06/17/2017	Compensatory Grant from Issuer
Common Stock	03/31/2018	Compensatory Grant from Issuer	Issuer			6209	03/31/2018	Compensatory Grant from Issuer
Common Stock	06/17/2018	Compensatory Grant from Issuer	Issuer			1167	06/17/2018	Compensatory Grant from Issuer
Common Stock	05/03/2019	Compensatory Grant from Issuer	Issuer			3780	05/03/2019	Compensatory Grant from Issuer
Common Stock	05/06/2019	Compensatory Grant from Issuer	Issuer			5725	05/06/2019	Compensatory Grant from Issuer
Common Stock	05/15/2024	Exercise of SARs	Issuer			6505	05/15/2024	Exercise of SARs
Common Stock	10/01/2024	Exercise of SARs	Issuer			8520	10/01/2024	Exercise of SARs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PSIX's Form 144 disclose about the planned sale?

The filing discloses a proposed sale of 26,005 common shares through Wells Fargo Advisors on NASDAQ, with an aggregate market value of $2,492,600.

How large is the planned sale relative to PSIX's outstanding shares?

The filing lists 23,029,846 shares outstanding, so the proposed sale equals approximately 0.113% of outstanding shares.

How were the shares being sold originally acquired according to the filing?

The shares were acquired via compensatory grants and exercises of SARs between 2016 and 2024 in multiple lots (examples: 786; 1,167; 6,209; 8,520).

Did the filer report any sales of issuer securities in the past three months?

The Form 144 shows Nothing to Report under securities sold during the past three months.

Does the filer claim possession of undisclosed material information?

By signing the notice the filer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.